Hong Kong (HKSAR) – The Department of Health (DH) today (March 4) ordered a licensed drug company, GlaxoSmithKline Ltd. (GSK), to recall from the market 144 units of three of its vaccines because of suspected quality defect. The products to be recalled are 115 units of Fluarix vaccine (Registration No.: HK-43003; Batch No.: AFLUA510AB) from […]
Gates Foundation Invests $10million in Vaccines Developer
By Meg Tirrell The Bill & Melinda Gates Foundation invested $10 million in Liquidia Technologies, a closely held biotechnology company developing vaccines, as part of a $400 million initiative to fund activities to help poorer countries. Liquidia is developing a seasonal flu vaccine and has an agreement with the PATH Malaria Vaccine Initiative to use […]
Interview: Novavax's CEO discusses HHS flu vaccine funding
By Maureen Marino Earlier this week, the HHS doubled down on new vaccine technology. The government granted Maryland-based Novavax a contract worth up to $179.1 million, while Cranbury, NJ’s VaxInnate picked up a potential $196 million deal. Both companies are developing new approaches to seasonal and pandemic influenza that could help the country move away from slower, […]
MMDA spearheads cervical cancer protection for women traffic enforcers
MANILA, Philippines (PNA) — In a fitting tribute to the celebration of Women’s Month, the Metropolitan Manila Development Authority (MMDA) spearheaded an information drive against cervical cancer for its women traffic enforcers and employees. Corazon Jimenez, MMDA general manager, led the information dissemination program last Tuesday in coordination with GlaxoSmithKline (GSK), aimed at increasing the […]
Research and Markets: Global Vaccine Market Report: Chronic Diseases and Flu Vaccines Driving the Market
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Vaccine Market” report to their offering. Over the last few years vaccine has been one of the important contributors of healthcare revenue across the globe. The vaccine industry is experiencing a new, more dynamic period. Since the year 2000, the global vaccine market has […]
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 57
- Next Page »
